{"id":12878,"date":"2020-08-18T01:18:31","date_gmt":"2020-08-18T05:18:31","guid":{"rendered":"https:\/\/cahr.wpengine.com\/?page_id=12878"},"modified":"2020-08-27T17:54:18","modified_gmt":"2020-08-27T21:54:18","slug":"webinaire-sur-le-vih-et-le-covid-19-partie-2","status":"publish","type":"page","link":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/","title":{"rendered":"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada &#8211; Partie 2"},"content":{"rendered":"<p>&nbsp;<br \/>\n<strong>Date de diffusion <\/strong>: <strong>mardi 25 <span lang=\"fr\">ao\u00fbt<\/span><\/strong><br \/>\n<strong>Organis\u00e9e par: Association canadienne de recherche sur le VIH<br \/>\nCommanditaire: Gilead<\/strong><\/p>\n<p>La nature de la pand\u00e9mie de la COVID-19 \u00e9voluant rapidement, il n\u2019y a eu que peu de recherches et d\u2019observations cliniques sur les r\u00e9percussions du virus chez les personnes s\u00e9ropositives au VIH. De la sorte, l\u2019Association canadienne de recherche sur le VIH (ACRV) organise un webinaire d\u2019enseignement qui r\u00e9unira un groupe de cliniciens des maladies infectieuses et de pharmaciens et fera ressortir les consid\u00e9rations cliniques lors du traitement des patients atteints de la COVID-19 (ou risquant de la contracter). Il s\u2019agit du deuxi\u00e8me webinaire d\u2019une s\u00e9rie et il qui tire parti des discussions diffus\u00e9es en avril 2020.<\/p>\n<p>L\u2019expos\u00e9 de nature clinique (en anglais) portera sur les domaines suivants :<\/p>\n<ul>\n<li>Mise \u00e0 jour \u00e9pid\u00e9miologique de la situation de la COVID-19 au Canada<\/li>\n<li>Questions et consid\u00e9rations essentielles pour les cliniciens du domaine du VIH<\/li>\n<li>Exemples de strat\u00e9gies de traitement en cours de mise en \u0153uvre dans l\u2019ensemble du Canada<\/li>\n<\/ul>\n<div>Pour visualiser le webinaire, voici l\u2019adresse : <a href=\"https:\/\/www.youtube.com\/watch?v=agvSySXauaY\">https:\/\/www.youtube.com\/watch?v=agvSySXauaY<\/a><\/div>\n<p>&nbsp;<\/p>\n<div><\/div>\n<div>Nos remerciements \u00e0 Gilead de son soutien \u00e0 ce projet.<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-11539 alignleft\" src=\"\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/Gilead-logo-V2.jpg\" alt=\"\" width=\"261\" height=\"87\" srcset=\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/Gilead-logo-V2.jpg 432w, https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/Gilead-logo-V2-300x100.jpg 300w\" sizes=\"auto, (max-width: 261px) 100vw, 261px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Date de diffusion : mardi 25 ao\u00fbt Organis\u00e9e par: Association canadienne de recherche sur le VIH Commanditaire: Gilead La nature de la pand\u00e9mie de la COVID-19 \u00e9voluant rapidement, il n\u2019y a eu que peu de recherches et d\u2019observations cliniques sur les r\u00e9percussions du virus chez les personnes s\u00e9ropositives au VIH. De la sorte, l\u2019Association [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"parent":496,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-12878","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV\" \/>\n<meta property=\"og:description\" content=\"&nbsp; Date de diffusion : mardi 25 ao\u00fbt Organis\u00e9e par: Association canadienne de recherche sur le VIH Commanditaire: Gilead La nature de la pand\u00e9mie de la COVID-19 \u00e9voluant rapidement, il n\u2019y a eu que peu de recherches et d\u2019observations cliniques sur les r\u00e9percussions du virus chez les personnes s\u00e9ropositives au VIH. De la sorte, l\u2019Association [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/\" \/>\n<meta property=\"og:site_name\" content=\"ACRV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-27T21:54:18+00:00\" \/>\n<meta property=\"og:image\" content=\"\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/Gilead-logo-V2.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@CAHR_ACRV\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/webinaire-sur-le-vih-et-le-covid-19-partie-2\\\/\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/webinaire-sur-le-vih-et-le-covid-19-partie-2\\\/\",\"name\":\"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#website\"},\"datePublished\":\"2020-08-18T05:18:31+00:00\",\"dateModified\":\"2020-08-27T21:54:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/webinaire-sur-le-vih-et-le-covid-19-partie-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/webinaire-sur-le-vih-et-le-covid-19-partie-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/webinaire-sur-le-vih-et-le-covid-19-partie-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/accueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formation\",\"item\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/formation\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada &#8211; Partie 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/\",\"name\":\"ACRV\",\"description\":\"L'association canadienne de recherche sur le VIH\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#organization\",\"name\":\"Canadian Association for HIV Research\",\"alternateName\":\"CAHR\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cahr-organization-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cahr-organization-logo.png\",\"width\":696,\"height\":696,\"caption\":\"Canadian Association for HIV Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CanadianAssociationforHIVResearch\",\"https:\\\/\\\/x.com\\\/CAHR_ACRV\",\"https:\\\/\\\/bsky.app\\\/profile\\\/cahr-acrv.bsky.social\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CAHRACRV\",\"https:\\\/\\\/www.instagram.com\\\/cahr_acrv\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/canadian-association-for-hiv-research\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/","og_locale":"fr_FR","og_type":"article","og_title":"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV","og_description":"&nbsp; Date de diffusion : mardi 25 ao\u00fbt Organis\u00e9e par: Association canadienne de recherche sur le VIH Commanditaire: Gilead La nature de la pand\u00e9mie de la COVID-19 \u00e9voluant rapidement, il n\u2019y a eu que peu de recherches et d\u2019observations cliniques sur les r\u00e9percussions du virus chez les personnes s\u00e9ropositives au VIH. De la sorte, l\u2019Association [&hellip;]","og_url":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/","og_site_name":"ACRV","article_publisher":"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","article_modified_time":"2020-08-27T21:54:18+00:00","og_image":[{"url":"\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/Gilead-logo-V2.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@CAHR_ACRV","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/","url":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/","name":"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada - Partie 2 &#8211; ACRV","isPartOf":{"@id":"https:\/\/www.cahr-acrv.ca\/#website"},"datePublished":"2020-08-18T05:18:31+00:00","dateModified":"2020-08-27T21:54:18+00:00","breadcrumb":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/webinaire-sur-le-vih-et-le-covid-19-partie-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.cahr-acrv.ca\/fr\/accueil\/"},{"@type":"ListItem","position":2,"name":"Formation","item":"https:\/\/www.cahr-acrv.ca\/fr\/formation\/"},{"@type":"ListItem","position":3,"name":"VIH et COVID-19 : Consid\u00e9rations cliniques pour les professionnels de la sant\u00e9 au Canada &#8211; Partie 2"}]},{"@type":"WebSite","@id":"https:\/\/www.cahr-acrv.ca\/#website","url":"https:\/\/www.cahr-acrv.ca\/","name":"ACRV","description":"L'association canadienne de recherche sur le VIH","publisher":{"@id":"https:\/\/www.cahr-acrv.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cahr-acrv.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cahr-acrv.ca\/#organization","name":"Canadian Association for HIV Research","alternateName":"CAHR","url":"https:\/\/www.cahr-acrv.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","contentUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","width":696,"height":696,"caption":"Canadian Association for HIV Research"},"image":{"@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","https:\/\/x.com\/CAHR_ACRV","https:\/\/bsky.app\/profile\/cahr-acrv.bsky.social","https:\/\/www.youtube.com\/user\/CAHRACRV","https:\/\/www.instagram.com\/cahr_acrv\/","https:\/\/www.linkedin.com\/company\/canadian-association-for-hiv-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/pages\/12878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/comments?post=12878"}],"version-history":[{"count":0,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/pages\/12878\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/pages\/496"}],"wp:attachment":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/media?parent=12878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}